These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 21452282)

  • 41. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule.
    Pereboev AV; Nagle JM; Shakhmatov MA; Triozzi PL; Matthews QL; Kawakami Y; Curiel DT; Blackwell JL
    Mol Ther; 2004 May; 9(5):712-20. PubMed ID: 15120332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice.
    Wüest T; Both GW; Prince AM; Hofmann C; Löser P
    Vaccine; 2004 Jul; 22(21-22):2717-21. PubMed ID: 15246602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.
    Frelin L; Ahlén G; Alheim M; Weiland O; Barnfield C; Liljeström P; Sällberg M
    Gene Ther; 2004 Mar; 11(6):522-33. PubMed ID: 14999224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.
    Landi A; Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Viral Hepat; 2011 Oct; 18(10):700-13. PubMed ID: 20701679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti-tumor immunity in a murine colorectal cancer model.
    Kim HS; Kim CH; Park MY; Park JS; Park HM; Sohn HJ; Kim HJ; Kim SG; Oh ST; Kim TG
    Immunol Lett; 2010 Jun; 131(1):73-80. PubMed ID: 20211203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.
    Wertheimer AM; Miner C; Lewinsohn DM; Sasaki AW; Kaufman E; Rosen HR
    Hepatology; 2003 Mar; 37(3):577-89. PubMed ID: 12601356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
    Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Major histocompatibility complex class-I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation.
    Hiasa Y; Takahashi H; Shimizu M; Nuriya H; Tsukiyama-Kohara K; Tanaka T; Horiike N; Onji M; Kohara M
    J Med Virol; 2004 Oct; 74(2):253-61. PubMed ID: 15332274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
    Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B
    Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial).
    Chernykh E; Leplina O; Oleynik E; Tikhonova M; Tyrinova T; Starostina N; Ostanin A
    Immunol Res; 2018 Feb; 66(1):31-43. PubMed ID: 29164490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.
    Krishnadas DK; Ahn JS; Han J; Kumar R; Agrawal B
    Int Immunol; 2010 Jun; 22(6):491-502. PubMed ID: 20410260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.
    Puig M; Mihalik K; Tilton JC; Williams O; Merchlinsky M; Connors M; Feinstone SM; Major ME
    Hepatology; 2006 Sep; 44(3):736-45. PubMed ID: 16941702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
    Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
    Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
    Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation.
    Tu Z; Hamalainen-Laanaya HK; Nishitani C; Kuroki Y; Crispe IN; Orloff MS
    Int Immunol; 2012 Feb; 24(2):97-106. PubMed ID: 22190574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice.
    Takei S; Omoto C; Kitagawa K; Morishita N; Katayama T; Shigemura K; Fujisawa M; Kawabata M; Hotta H; Shirakawa T
    Vaccine; 2014 May; 32(25):3066-74. PubMed ID: 24657718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.